Talquetamab Effective in Post T-Cell Therapy Setting for R/R Myeloma
Anthracycline Plus Chemo Lowers Risk for Recurrence in MP High-2–Risk, HR+/HER2– Early Breast Cancer
T-DXd Extends Progression-Free Survival in Pretreated HR+, HER2-Low and -Ultralow Metastatic Breast Cancer
Telehealth Palliative Care Equally Beneficial as In-Person Visits in Advanced NSCLC